An integrated analysis of gene expression and chromosome copy number in malignant mesothelioma [ 2007 - 2011 ]

Also known as: CGH analysis of mesothelioma

Research Grant

[Cite as]

Researchers: Dr Andrew Holloway (Principal investigator) ,  Prof Richard Lake

Brief description Mesothelioma is an aggressive, asbestos related cancer which causes more than 20,000 deaths worldwide per annum. Mesothelioma is characterised by a long latency between exposure to asbestos and development of the disease, estimated to be between 20 and 40 years. As such, the peak number of cases of mesothelioma is not expected in Australia until 2010, as asbestos use reached its peak in the 1970-80's. In 2010, deaths from mesothelioma will be more common than ovarian cancer and melanoma. This study aims to explore the molecular defects that are involved in initiation and progression of mesothelioma. Using array comparative genomic hybridisation, a technique which allows comparison of the DNA of normal cells with that of cancer cells, we will classify chromosomal changes in the cancer cell and identify candidate genes which are involved in mesothelioma development.

Funding Amount $AUD 421,697.38

Funding Scheme Targeted Calls

Notes Asbestos diseases related research grants

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]